Company Overview
Snapshot
Founded in March 2012 by Eyal Bercovich and Isaac Tal, Gynamics operates with 1–10 employees. The company has developed NOLIX, an intra-vaginal medical device for women suffering from stress urinary incontinence (SUI), which has successfully completed a proof-of-concept clinical trial.
Business overview
Gynamics is a Health Tech & Life Sciences company focused on improving the lives of women suffering from stress urinary incontinence (SUI) and pelvic organ prolapse. The company's core product is NOLIX, an air-filled silicone intra-vaginal medical device designed to provide dynamic urethral support by utilizing natural abdominal pressure to prevent urine leakage. Resembling a tampon, NOLIX is intended for over-the-counter purchase and offers up to 12 hours of use. Gynamics operates within the medical devices sector, targeting consumers and patients in the women's health market globally.
Log in to access full profile ›Company Intelligence Q&A
- What is Gynamics' primary product?
- Gynamics' primary product is NOLIX, an intra-vaginal medical device designed to treat stress urinary incontinence (SUI) and pelvic organ prolapse in women. It is an air-filled silicone device that provides dynamic urethral support.
- What is the current development stage of the NOLIX device?
- The NOLIX device has successfully completed a proof-of-concept clinical trial and is currently moving into mass production.
- What problem does Gynamics aim to solve?
- Gynamics aims to improve the lives of women who suffer from stress urinary incontinence (SUI) and pelvic organ prolapse by providing a non-invasive, over-the-counter medical device solution.
- Who are the founders of Gynamics?
- Gynamics was founded by Eyal Bercovich and Isaac Tal.
- What is the intended use and duration of the NOLIX device?
- The NOLIX device is designed for over-the-counter purchase and use, providing up to 12 hours of relief for women with stress urinary incontinence.